Annual CAPEX
$145.69 M
-$257.68 M-63.88%
01 December 2023
Summary:
Sinovac Biotech annual capital expenditures is currently $145.69 million, with the most recent change of -$257.68 million (-63.88%) on 01 December 2023. During the last 3 years, it has risen by +$18.04 million (+14.13%). SVA annual CAPEX is now -79.76% below its all-time high of $719.98 million, reached on 31 December 2021.SVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly capital expenditures is not available.SVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
01 June 2024
Summary:
Sinovac Biotech TTM capital expenditures is not available.SVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +14.1% | - | - |
| 5 y5 years | +2495.6% | - | - |
SVA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -79.8% | +14.1% | ||||
| 5 y | 5 years | -79.8% | +2495.6% | ||||
| alltime | all time | -79.8% | >+9999.0% |
Sinovac Biotech CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $145.69 M(-63.9%) | - | - |
| Dec 2022 | $403.37 M(-44.0%) | - | - |
| Dec 2021 | $719.98 M(+464.0%) | - | - |
| Dec 2020 | $127.65 M(+1101.1%) | $57.87 M(+73.6%) | $127.65 M(+78.0%) |
| Sept 2020 | - | $33.33 M(-0.4%) | $71.70 M(+76.0%) |
| June 2020 | - | $33.45 M(+1010.4%) | $40.74 M(+211.4%) |
| Mar 2020 | - | $3.01 M(+57.3%) | $13.08 M(+23.1%) |
| Dec 2019 | $10.63 M(+89.3%) | $1.92 M(-19.1%) | $10.63 M(+10.5%) |
| Sept 2019 | - | $2.37 M(-59.1%) | $9.62 M(+5.7%) |
| June 2019 | - | $5.79 M(+939.1%) | $9.10 M(+96.6%) |
| Mar 2019 | - | $557.00 K(-38.7%) | $4.63 M(-17.5%) |
| Dec 2018 | $5.61 M(-52.9%) | $908.00 K(-50.8%) | $5.61 M(+19.3%) |
| Sept 2018 | - | $1.85 M(+40.2%) | $4.71 M(+64.6%) |
| June 2018 | - | $1.32 M(-14.6%) | $2.86 M(+85.4%) |
| Mar 2018 | - | $1.54 M(-65.2%) | $1.54 M(-87.8%) |
| Dec 2017 | $11.91 M(-5.8%) | - | - |
| Dec 2016 | $12.65 M(+138.8%) | $4.43 M(+22.7%) | $12.65 M(+24.7%) |
| Sept 2016 | - | $3.61 M(+238.7%) | $10.15 M(+43.6%) |
| June 2016 | - | $1.07 M(-69.9%) | $7.07 M(+0.0%) |
| Mar 2016 | - | $3.54 M(+84.1%) | $7.06 M(+33.3%) |
| Dec 2015 | $5.30 M(-51.4%) | $1.93 M(+264.8%) | $5.30 M(-24.1%) |
| Sept 2015 | - | $528.00 K(-50.4%) | $6.98 M(-13.6%) |
| June 2015 | - | $1.06 M(-40.3%) | $8.07 M(-23.0%) |
| Mar 2015 | - | $1.78 M(-50.6%) | $10.49 M(-3.9%) |
| Dec 2014 | $10.91 M(+112.6%) | $3.61 M(+122.0%) | $10.91 M(+21.2%) |
| Sept 2014 | - | $1.62 M(-53.3%) | $9.00 M(+4.9%) |
| June 2014 | - | $3.48 M(+57.8%) | $8.58 M(+65.8%) |
| Mar 2014 | - | $2.20 M(+30.0%) | $5.18 M(+0.9%) |
| Dec 2013 | $5.13 M | $1.70 M(+40.7%) | $5.13 M(-40.7%) |
| Sept 2013 | - | $1.21 M(+1573.6%) | $8.65 M(-26.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | $72.00 K(-96.7%) | $11.77 M(-23.4%) |
| Mar 2013 | - | $2.16 M(-58.6%) | $15.36 M(-5.0%) |
| Dec 2012 | $16.16 M(+4.5%) | $5.21 M(+20.6%) | $16.16 M(-9.0%) |
| Sept 2012 | - | $4.32 M(+18.1%) | $17.75 M(+8.4%) |
| June 2012 | - | $3.66 M(+23.6%) | $16.38 M(-5.1%) |
| Mar 2012 | - | $2.96 M(-56.5%) | $17.26 M(+11.7%) |
| Dec 2011 | $15.46 M(-39.1%) | $6.81 M(+131.3%) | $15.46 M(-22.3%) |
| Sept 2011 | - | $2.95 M(-35.2%) | $19.91 M(-3.9%) |
| June 2011 | - | $4.54 M(+293.4%) | $20.71 M(+16.2%) |
| Mar 2011 | - | $1.15 M(-89.7%) | $17.82 M(-29.8%) |
| Dec 2010 | $25.38 M(+487.5%) | $11.26 M(+199.9%) | $25.38 M(+69.7%) |
| Sept 2010 | - | $3.76 M(+127.7%) | $14.96 M(+15.8%) |
| June 2010 | - | $1.65 M(-81.1%) | $12.92 M(+7.5%) |
| Mar 2010 | - | $8.71 M(+937.8%) | $12.02 M(+178.3%) |
| Dec 2009 | $4.32 M(+8.6%) | $839.60 K(-51.1%) | $4.32 M(+3.5%) |
| Sept 2009 | - | $1.72 M(+129.0%) | $4.17 M(+19.2%) |
| June 2009 | - | $750.50 K(-25.8%) | $3.50 M(-12.0%) |
| Mar 2009 | - | $1.01 M(+46.0%) | $3.98 M(+0.1%) |
| Dec 2008 | $3.98 M(+61.2%) | $693.00 K(-33.8%) | $3.98 M(+21.1%) |
| Sept 2008 | - | $1.05 M(-14.8%) | $3.28 M(+46.8%) |
| June 2008 | - | $1.23 M(+22.0%) | $2.24 M(+122.0%) |
| Mar 2008 | - | $1.01 M | $1.01 M |
| Dec 2007 | $2.47 M(+116.4%) | - | - |
| Dec 2006 | $1.14 M(-53.3%) | - | - |
| Dec 2005 | $2.44 M(+48.1%) | - | - |
| Dec 2004 | $1.65 M(+126.3%) | - | - |
| Dec 2003 | $729.20 K(>+9900.0%) | - | - |
| Apr 2002 | $800.00(-78.4%) | - | - |
| Apr 2001 | $3700.00(-92.2%) | - | - |
| Apr 2000 | $47.30 K | - | - |
FAQ
- What is Sinovac Biotech annual capital expenditures?
- What is the all time high annual CAPEX for Sinovac Biotech?
- What is the all time high quarterly CAPEX for Sinovac Biotech?
- What is the all time high TTM CAPEX for Sinovac Biotech?
What is Sinovac Biotech annual capital expenditures?
The current annual CAPEX of SVA is $145.69 M
What is the all time high annual CAPEX for Sinovac Biotech?
Sinovac Biotech all-time high annual capital expenditures is $719.98 M
What is the all time high quarterly CAPEX for Sinovac Biotech?
Sinovac Biotech all-time high quarterly capital expenditures is $57.87 M
What is the all time high TTM CAPEX for Sinovac Biotech?
Sinovac Biotech all-time high TTM capital expenditures is $127.65 M